Full Press Release Details
Hamby ME, Lizama BN, Reaver A, et al. Sigma-2 Receptor Modulation Promotes Retinal Pigment Epithelial Cell Survival Following Chronic 7-Ketocholesterol Exposure . Poster presented at ARVO 2025 ; Salt Lake City, UT
CGTX Positive Sentiment
Sigma-2 Receptor Modulation Promotes Retinal Pigment Epithelial Cell Survival Following Chronic 7-Ketocholesterol Exposure
Key Takeaway: The study presented by Hamby et al. at ARVO 2025 discusses the effects of sigma-2 receptor modulation on retinal pigment epithelial cell survival under chronic exposure to 7-ketocholesterol. The findings suggest that this modulation could provide therapeutic benefits for conditions affecting retinal cells. The research was showcased in Salt Lake City, UT.
Price reaction · baseline $0.33 (2025-05-08 close) · hit pre-market · 4 other CGTX headline(s) in the window, move may be shared
day 0 close · peak
-8.8%
day 1
-0.9%
day 3
+1.1%
Market Sentiment Analysis
POSITIVE FACTORS
- Research highlights potential therapeutic benefits.
- Promotes cell survival in retinal pigment epithelial cells.
- Focus on sigma-2 receptor modulation shows promise.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+35%
120-day peak, hindsight
Typical move
8.3%
average across 6 past catalysts
Cash runway
~33 mo
Minimal dilution risk
Lead asset
Oxytocin
Phase 2 · Oxidative Stress
Frequently Asked Questions
What was the focus of the study presented at ARVO 2025?
The study focused on sigma-2 receptor modulation and its effects on retinal pigment epithelial cell survival.
Who conducted the research on sigma-2 receptor modulation?
The research was conducted by Hamby ME, Lizama BN, Reaver A, and colleagues.
Where was the study on sigma-2 receptor modulation presented?
The study was presented at the ARVO 2025 conference in Salt Lake City, UT.
What condition does the research aim to address?
The research aims to address cell survival issues related to chronic 7-ketocholesterol exposure.